Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
IVF hartmann Holding AGXSWX:VBSN 73 Net-Net Working Capital is CHF41.86 as of Dec. 2025. GuruFocus rates XSWX:VBSN with a GF Score™ of 73/100 and a GF Value™ of CHF143.43 (Modestly Undervalued). Among 420 Medical Devices & Instruments companies, IVF hartmann Holding AG ranks better than 76.9% on this metric.
In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. This is a conservative way of estimating the company's value.
IVF hartmann Holding AG's Net-Net Working Capital for the quarter that ended in Dec. 2025 was CHF41.86.
The industry rank for IVF hartmann Holding AG's Net-Net Working Capital or its related term are showing as below:
XSWX:VBSN's Price-to-Net-Net-Working-Capital is ranked better than 76.9% of 420
companies
in the Medical Devices & Instruments industry
Industry Median: 6.635
vs XSWX:VBSN: 3.03
IVF hartmann Holding AG (XSWX:VBSN) Net-Net Working Capital Explanation
One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.
Benjamin Graham looked for companies whose market values were less than two-thirds of their net-net value. They are collected under our Net-Net screener.
IVF hartmann Holding AG Net-Net Working Capital Related Terms
IVF hartmann Holding AG Net-Net Working Capital Historical Data
* Premium members only.
The historical data trend for IVF hartmann Holding AG's Net-Net Working Capital can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IVF hartmann Holding AG Net-Net Working Capital Chart
XSWX:VBSN vs ISRG, BDX, MDLN: Net-Net Working Capital Comparison
For the Medical Instruments & Supplies subindustry, IVF hartmann Holding AG's Price-to-Net-Net-Working-Capital, along with its competitors' market caps and Price-to-Net-Net-Working-Capital data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IVF hartmann Holding AG Price-to-Net-Net-Working-Capital vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, IVF hartmann Holding AG's Price-to-Net-Net-Working-Capital distribution charts can be found below:
* The bar in red indicates where IVF hartmann Holding AG's Price-to-Net-Net-Working-Capital falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full.
In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.
This is a conservative way of estimating the company's value.
What does a Net-Net Working Capital of CHF41.86 mean?
IVF hartmann Holding AG (XSWX:VBSN) has a Net-Net Working Capital of CHF41.86 as of Dec. 2025. Ben Graham defined net-net working capital as the per-share sum of cash, 75% of receivables and 50% of inventory less total liabilities. View historical data on IVF hartmann Holding AG According to the industry distribution chart, IVF hartmann Holding AG ranks #97 out of 420 companies in the Medical Devices & Instruments industry, placing it in the top 23.1%.
Is IVF hartmann Holding AG's Net-Net Working Capital too high?
IVF hartmann Holding AG's current Net-Net Working Capital is CHF41.86. Based on the distribution chart, IVF hartmann Holding AG ranks #97 out of 420 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, IVF hartmann Holding AG has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does IVF hartmann Holding AG's Net-Net Working Capital compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, IVF hartmann Holding AG ranks #97 out of 420 companies for Net-Net Working Capital. This places IVF hartmann Holding AG in the top 23% of its industry — outperforming the majority of peers. The industry median Net-Net Working Capital is 6.64. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net-Net Working Capital for a Medical Devices & Instruments company?
The median Net-Net Working Capital among Medical Devices & Instruments companies is 6.64, based on 420 companies in the industry. Companies in the top quartile (top 25%) have a Net-Net Working Capital significantly above this median, while those in the bottom quartile fall well below. However, Net-Net Working Capital should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net-Net Working Capital mean?
A high Net-Net Working Capital can signal that a stock is expensive relative to its fundamentals. Ben Graham defined net-net working capital as the per-share sum of cash, 75% of receivables and 50% of inventory less total liabilities. View historical data on IVF hartmann Holding AG For the Medical Devices & Instruments industry, the median Net-Net Working Capital is 6.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IVF hartmann Holding AG's current Net-Net Working Capital is CHF41.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IVF hartmann Holding AG stock overvalued right now?
Based on GuruFocus' analysis, IVF hartmann Holding AG (XSWX:VBSN) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF143.43, compared to a current price of CHF127.00 — trading 11.5% below its estimated fair value. The current Net-Net Working Capital is CHF41.86. IVF hartmann Holding AG's overall GF Score™ is 73/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net-Net Working Capital calculated?
Net-Net Working Capital is calculated from a company's financial statements. For IVF hartmann Holding AG (XSWX:VBSN), the current Net-Net Working Capital is CHF41.86 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IVF hartmann Holding AG (XSWX:VBSN) Overvalued in 2026?
Based on GuruFocus' analysis, IVF hartmann Holding AG stock appears to be undervalued.
The current stock price of CHF127.00 is trading 11.5% below its estimated GF Value™ of CHF143.43.
GuruFocus considers IVF hartmann Holding AG to be Modestly Undervalued.
Key valuation signals for XSWX:VBSN:
Net-Net Working Capital: CHF41.86
GF Value™: CHF143.43 vs. price of CHF127.00 (11.5% below fair value)
No single metric tells the full story. See the XSWX:VBSN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
IVF hartmann Holding AG engages in production and supply of medical, pharmaceutical and hygiene products in Switzerland, it offers products such as surgical disposable, disposable dental, first aid, therapeutic plaster, cotton wool, wound care among others. The company operates in four segment wound care, incontinence management, infection management and Other group activities.
73GF Score
Get the complete analysis for XSWX:VBSN
Net-Net Working Capital is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:VBSN has been successfully added to your 
